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Nuclear reprogramming is the name given to the change 
that occurs in the nucleus of a somatic cell when it is 
induced to revert from its differentiated state and 
assumes a pluripotent state, from which it can adopt any 
cellular identity, given the appropriate cues. This is the 
basis for much of the promise in regenerative medicine, 
for example in the repopulation of bone marrow follow­
ing chemotherapy. In a laboratory setting, repro gram­
ming can be achieved in two ways. In the first, the 
somatic cell nucleus is transferred into an oocyte. Here 
the oocyte provides the necessary factors to reprogram 
the somatic nucleus, which is in principle then capable of 
recapitulating the entire developmental program. In the 
second, expression of four key transcription factors 
(Oct4, Sox2, Klf4 and c­Myc) is sufficient to reprogram a 
somatic cell to produce what is known as an induced 
pluripotent stem cell (iPSC) state, originally discovered 
by Shinya Yamanaka and colleagues [1].
There are, however, several hurdles to be overcome 
before reprogrammed cells can be used in a therapeutic 
setting. Currently, the generation of iPSCs is typically 
slow and the reprogramming of somatic cells from 
accessible adult tissues, which is most applicable for 
therapeutic uses, is particularly inefficient because donor 
cells from these tissues are at a late stage of differentiation 
[2]. It also appears that iPSCs are not truly equivalent to 
the pluripotent embryonic stem cell, as iPSCs display a 
reduced differentiation capacity that is biased to the cell 
lineage of origin. This is consistent with the observation 
that iPSCs may retain a memory of the somatic cell gene 
expression pattern. An important aim of research in this 
field, therefore, is a better understanding of the mecha­
nism of reprogramming that may lead to improvements 
in the efficiency and fidelity with which pluripotent stems 
cells can be generated. Such an understanding is begin­
ning to emerge from studies on chromatin remodeling in 
the generation of pluripotent stem cells.
Resetting the chromatin landscape
Studies on iPSC generation have suggested that chroma tin 
at the promoters and enhancers of pluripotency genes in 
somatic cells is in a repressed state characterized by 
modifications such as DNA methylation and histone 
deacetylation, and this is a roadblock to reprogramming, 
which is thus promoted by inhibitors of DNA methylation 
and histone deacetylation [3]. c­Myc is thought to 
function as a catalyst in this process, by increasing the 
rate of cell proliferation and perhaps transcriptional 
elongation, both of which result in large­scale chromatin 
remodeling.
In the study reported in Epigenetics & Chromatin, John 
Gurdon and colleagues describe the investigation of 
reprogramming that is independent of DNA replication, 
by transferring mammalian somatic cell nuclei into 
Xenopus oocytes, which are mitotically arrested, and 
following the resulting chromatin changes [4]. They 
focused on the incorporation of the histone variant H3.3, 
which is a hallmark of sites of high nucleosome turnover, 
and is associated with active genes and their regulatory 
elements [5,6]. When they microinjected mRNA encod­
ing epitope­tagged H3.3 into the oocytes prior to nuclear 
transfer, they observed early incorporation of H3.3 into 
the pluripotency gene Oct4 coincident with the onset of 
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transcription of the gene. To check the requirement for 
H3.3, they injected into the oocyte polyclonal antibodies 
against HIRA, the chaperone responsible for the incor­
poration of histone H3.3 into chromatin, and were able to 
show that this abrogates transcriptional reprogramming. 
They also showed, by the use of the polymerase II 
inhibitor alpha­amanitin, that H3.3 incorporation depends 
on transcriptional activity as well as HIRA. Impaired 
reprogramming in the absence of HIRA and H3.3 
deposition could not be compensated for by the increased 
deposition of histone variant H3.2. These results imply 
that some specific function is attributable to the H3.3 
deposition pathway in promoting reprogramming, and 
raises the question of what that function might be.
Reprogramming is far less efficient than differentiation 
and this may reflect the need for reprogramming factors 
to overcome changes to the chromatin environment that 
occur with differentiation. Embryonic stem cells are 
characterized by a highly dynamic chromatin state 
compared with that of more differentiated cell types [7], 
and pluripotency genes in particular have been shown to 
gain repressive chromatin marks during differentiation. It 
is, however, at these silenced sites that the reprogram­
ming factors must bind to elicit their effects. Whilst 
c­Myc binding occurs early in the reprogramming 
process, Oct4, Sox2 and to a lesser extent Klf4, which co­
occupy a large number of promoters, bind only later 
during reprogramming. Delayed binding of Oct4, Sox2 
and Klf4, presumably because of the repressive chromatin 
environment at their binding sites, is thought to be a 
major roadblock in the reprogramming process.
As transcription factor binding sites associated with 
active genes are marked by rapidly turning­over nucleo­
somes, it is probable that during reprogramming the 
nucleosomes at the Oct4/Sox2/Klf4 sites become re­
modeled to contain H3.3. The high turnover observed at 
regulatory sites might be required to prevent sites from 
becoming stably occupied by nucleosomes, which would 
impede transcription factor binding and therefore 
reprogramming. This removal of repressive chromatin 
and replacement with H3.3 may facilitate transcription 
factor binding and successful reprogramming. Perhaps, 
therefore, HIRA­dependent H3.3 deposition is function­
ing to promote pluripotency. This is consistent with the 
observation that HIRA deficient embryonic stem cells 
rapidly differentiate [7]. It also, however, raises the ques­
tion of how histone H3.3 may confer a more accessible 
chromatin environment.
Histone H3.3: striking a balance
One obvious possibility is that the high turnover of H3.3­
containing nucleosomes reflects some intrinsic insta­
bility. However, H2A/H3.3­containing nucleosomes seem 
to be just as stable in vitro as H2A/H3.1­containing 
nucleosomes [8]. Another possibility is that histone H3.3 
accumulates at these high turnover sites as a gap­filling 
mechanism after the eviction of nucleosomes following 
transcription or the activity of chromatin remodelers. 
The observations of Gurdon and colleagues, however, 
indicate failure of histone variant H3.2 to compensate for 
the lack of H3.3 deposition, suggesting that there is more 
to H3.3 deposition in the reprogramming process than 
simple gap filling.
If there is nothing intrinsic to the amino acid sequence 
of H3.3 that favors a permissive chromatin state, then 
perhaps the deposition process itself is key. Perhaps, 
therefore, a specific post­translational modification of 
H3.3 might be associated with HIRA­dependent deposi­
tion, or an additional chromatin remodeling step at the 
point of H3.3 deposition might promote an active chro­
matin conformation and accessibility to the underlying 
DNA sequence. iPSC generation has been suggested to 
be a stochastic process [9], which at a molecular level 
may reflect the stochastic nature of binding by the 
reprogramming factors to their target sequences due to 
transient exposure of these sites in the repressive 
chromatin environment [10]. Increases in the deposition 
of H3.3 may therefore facilitate reprogramming by 
increas ing the frequency of exposure of these binding 
sites (Figure 1a).
A key question for future studies is whether the over­
expression of HIRA and/or histone H3.3 may accelerate 
reprogramming and increase the efficiency of iPSC 
generation by allowing the remodeling of transcription 
factor binding sites. A second, related question is 
whether such overexpression might provide the neces­
sary replication­independent chromatin remodeling, 
thereby reducing the requirement for c­Myc as a catalyst. 
This would be desirable because c­Myc, which is thought 
to aid reprogramming by increasing the rate of cell 
proliferation and thereby genome­wide chromatin 
remodeling, is a proto­oncogene; there are thus naturally 
concerns about its induced expression in the generation 
of iPSCs as a therapeutic agent.
There is, however, a potential pitfall in the over­
expression of HIRA/H3.3 in reprogramming. Whilst it 
may allow the remodeling of repressive chromatin to 
promote gene activation, histone H3.3 has also been 
shown in an earlier study by Gurdon and colleagues [11] 
to potentiate transcriptional memory (Figure 1b). In that 
study, using reprogramming via somatic cell nuclear 
transfer into enucleated Xenopus oocytes, they showed 
that overexpression of histone H3.3 increased the fre­
quency at which nuclei maintained their original trans­
criptional program, as determined by MyoD expression. 
They have since suggested that the unusually high H3.3 
content in eggs is responsible for this trans criptional 
memory [2]. This may suggest the need for a delicate 
Skene and Henikoff BMC Biology 2012, 10:83 
http://www.biomedcentral.com/1741-7007/10/83
Page 2 of 3
balance in the overexpression of HIRA and/or H3.3, in 
which factor binding will be facilitated through chroma­
tin decondensation, but transcriptional memory will not 
be evoked. Given the evidence that trans crip tional 
memory in iPSCs may cause some of the observed 
limitations to the regenerative applications of these cells, 
clearly the operation of the H3.3 pathway in both re­
programming and memory will need to be taken into 
account in any manipulation of that pathway for thera­
peutic purposes. Gurdon’s latest work thus forges a 
connection, through the changes to chromatin required 
for reprogramming, between the two 2012 Nobel Prize­
winning papers published almost a half century apart.
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Figure 1. Opposing roles of histone H3.3 in reprogramming. (a) In somatic cells, pluripotency genes are in a repressive chromatin environment. 
Transient binding by a reprogramming factor to its binding site results in histone H3.3 incorporation, which in turn results in a more permissive 
chromatin structure and enhanced accessibility of the binding site. These chromatin changes increase the probability of concomitant binding 
of Oct4, Sox2 and Klf4 and activation of the target pluripotency gene. (b) Active genes are marked by high levels of histone H3.3. During DNA 
replication H3.3 is diluted out by the replication-dependent incorporation of histone H3.1. Depending on appropriate cues the gene will either 
become re-activated or become silenced. During reprogramming, tissue-specific genes become progressively silenced. High levels of H3.3 
expression, however, increase the probability of H3.3 incorporation and therefore promote the memory of the somatic cell gene expression pattern.
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